Erratum - Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer

DOI:10.33594/000000650
Published online 31 August 2023

Erratum

In the article “Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer”. (Cell Physiol Biochem, 2017, 44: 1471-1484. DOI:10.1159/000485583) by Jin et al., the authors identified that the images in the Fig. 3A, Fig. 3C and the representative TUNEL image for Figure 6F Apatinib are incorrect.

For Fig. 3A and Fig.3C, during this study, the authors state that one person was responsible for transwell experiments, drawing statistical charts, and then sending the images and charts to another person to assemble the final figure. The wrong representative images for the CAL-62 cell line in Figure 3A and Figure 3C were inadvertently selected when assembling the final figure.

The incorrect representative TUNEL images for Figure 6F Control and Apatinib group were included. The authors stated that they assembled Figure 6 using Figure 7 of another article by the group (Mol Oncol, 2018, 12: 529-544) as a template.

The correct Figure 3 and Figure 6 can be found below.


...

Figure 3


...

Figure 6